期刊文献+

结合雌激素片治疗围绝经期功血患者的临床疗效 被引量:1

Efficacy of Conjugated Estrogens Tablets in the Treatment of Perimenopausal Dysfunctional Uterine Bleeding
下载PDF
导出
摘要 目的探究结合雌激素片对围绝经期功血患者的临床疗效。方法回顾性分析2016年05月~2017年05月本院收治的围绝经期功血患者102例临床资料,分为对照组和观察组,各51例。对照组采用醋酸甲羟孕酮片进行治疗,观察组采用结合雌激素片进行治疗,对比两组临床疗效。结果 观察组治疗总有效率92.16%(47/51),对照组74.51%(38/51),差异具有统计学意义(P<0.05);促卵泡生长激素(FSH)促黄体生成素(LH)、雌二醇(E2)、孕酮(P)、水平:观察组均低于为对照组,两组差异具有统计学意义(P<0.05);观察组子宫内膜厚度为(0.47±0.04)cm,对照组(0.65±0.06)cm,两组差异具有统计学意义(P<0.05);观察组血红蛋白水平为(103.42±8.37)g/L,对照组(90.15±7.24)g/L,两组差异具有统计学意义(P<0.05);停药后随访3个月,观察组患者复发率为5.88%(3/51),对照组21.57%(11/51),两组差异具有统计学意义(P<0.05)。结论结合雌激素片可有效提升围绝经期功血患者临床疗效,改善子宫内膜厚度。 Objective:To investigate the efficacy of conjugated estrogens tablets in the treatment of perimenopausal dysfunctional uterine bleeding.Methods:In total,102 patients with perimenopausal dysfunctional uterine bleeding were admitted and treated in our hospital from May 2016 to May 2017.They were randomly divided into test group(n=51)and test group(n=51).Patients in control group were treated with medroxyprogesterone acetate tablets,while patients in test group were treated with conjugated estrogens tablets.The treatment results were compared between the two groups.Results:(1)The total efiective rate of test group(92.16%)was significant higher than that of control group(74.51%).(2)The levels of FSH,LH,and E2 in test group were significantly lower than those in control group.(3)The endometrial thickness of test group was(0.47±0.04)cm and that of the control group was(0.65±0.06)cm,there was significant difierence.(4)The HB level of test group was(103.42+8.37)g/L and that of the control group was(90.15+7.24)g/L,there was significant difierence.(5)Three months after drug withdrawal,the recurrence rate in test group(5.88%)was significantly lower than that in control group(21.57%)(P<0.05).Conclusions:Conjugated estrogens tablets can improve treatment result as well as the endometrial thickness.
作者 梁诗翠 Shicui Liang(Department of Obstetrics,Tongbai Third People's Hospital,Nanyang,Henan 474750,China)
出处 《西藏医药》 2020年第2期74-77,共4页 Tibetan Medicine
关键词 围绝经期功血 结合雌激素片 血红蛋白 子宫内膜厚度 Perimenopausal Dysfunctional Uterine Bleeding Conjugated Estrogens Tablets HB Endometrial Thickness
  • 相关文献

参考文献10

二级参考文献106

  • 1Shan Bao,Shu-Ying Yang,Zhuo-Ri Li,Ge-Bo Wen.Comparison on serum biomarkers for anovulatory and ovulatory dysfunctional uterine bleeding in Lizu females[J].Asian Pacific Journal of Tropical Medicine,2014,7(2):149-152. 被引量:11
  • 2李春芳.围绝经期功能失调性子宫出血的治疗进展[J].中国厂矿医学,2006,19(2):174-176. 被引量:2
  • 3Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3 [J]. Nat Rev Cancer,2009, 9 (11): 798-809.
  • 4Gao J, Tian J, Lv Y, et al. Leptin induces functional activa tion of cyclooxygenase -2 through JAK2/STAT3, MAPK/ ERK, and PI3K/AKT pathways in human endometrial cancer cells [J] . Cancer Sci, 2009, 100 (3): 389-395.
  • 5Mylonas I, Makovitzky J, Friese K, et al. Immunohistochemical labelling of steroid receptors in normal and malignant human endometrium [J].Acta Histochem, 2009, 111 (4): 349 - 359.
  • 6Kayastha S.Study of endometrial tissue in dysfunctional uterine bleeding.Nepal Medical College Journal:NMCJ,2013,15(1):27-30.
  • 7Subhasish Ghosh,Subhankar Chatterjee.Molecular blockade of angiogenic factors:A new therapeutic tool for the treatment of abnormal uterine bleeding.Journal of Mid-life Health,2013,4(1):66-67.
  • 8Karimi-Zarchi M, Dehghani-Firoozabadi R, Tabatabaie A, et al. A comparison of the effect of levonorgestrel IUD with oral medroxyprogesterone acetate on abnormal uterine bleeding with simple endometrial hyperplasia and fertility preservation [J]. Clin Exp Obstet Gynecol, 2013, 40(3) : 421-424.
  • 9Panda S, Jha V, Singh S. Ro|e of combination of Mifepristone and Misoprostol verses Misoprostol alone in induction of labour in late intrauterin fetal death, a prospective study [J]. J Family Reprod Health, 2013, 7(4) : 177-179.
  • 10Behnamfar F, Ghahiri A, Tavakoli M. Levonorgestrel- releasing intrauterine system (Mirena) in compare to medroxyprogesterone acetate as a therapy for endometrial hyperplasia. J Res Med Sci, 2014, 19(8):686-90.

共引文献321

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部